CTN-0080-A-3: Improved Messaging Strategies for MOUD for Underserved Populations of Pregnant and Postpartum Individuals with OUD
Frankie B. Kropp, MS, LICDC-CS
Principal Investigator
OVN Node Coordinator
University of Cincinnati College of Medicine
kroppfb@ucmail.uc.edu
This project will develop stigma-reduction and educational messages related to opioid use disorder and medication for opioid use disorder in pregnant / postpartum (PP) persons including: (1) NOWS; (2) the importance of MOUD for maternal and infant health, (3) stigma and health system mistrust, and (4) PP persons rights to treatment. The project team will create products tailored to specific populations (Hispanic, Black, and Native PP women, and those living in rural areas), engage consumers and advisors for review and feedback, and work with CTN leadership and the IMPROVE COE Implementation Hub to finalize and disseminate the developed messaging to providers, consumers, and the general public.
Related Studies
- CTN-0080: Medication Treatment for Opioid-dependent Expecting Mothers (MOMs): A Pragmatic Randomized Trial Comparing Two Buprenorphine Formulations (NIH HEAL Initiative)
- CTN-0080-A-1: Successful Recruitment and Retention in a Randomized Controlled Trial of Pregnant People with Opioid Use Disorder (SUCCESS STUDY)
- CTN-0080-A-2: Promoting Research with Mothers receiving OUD Treatment; a focus on Equity (PRoMOTE)
Related Resources
Node Involvement
Lead Node(s):